The biotechs will assess a combination of two drugs against HER2-positive breast cancer. Elsewhere, Merck unveiled the latest ...

The plans, if implemented, would result in the layoff of about 365 employees. Galapagos said it will still entertain ...

Presented at the European Society for Medical Oncology, study results showed Datroway extended survival in breast cancer ...

A closely watched trial in Chinese patients is raising hope that ivonescimab will outperform Keytruda in a large global study ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.